Webinar
Considerations and Opportunities in Capturing Oncology Patients’ PRO Data
There has been a historic lack of guidance in capturing patient data for oncology patients. Join Bill Byrom, VP and eCOA Scientist at Signant Health in conversation with Mark Wade, Global Practice Leader at TransPerfect, as they discuss:
- The need for specificity of instruments to lead to greater use of PRO data in labeling claims
- The impact of the draft FDA guidance to instrument selection and COA measurement strategy
- The potential of item banks and augmentation of current tools
- Considerations for reducing the patient burden in the study design
